The FDA is prohibited from going germline

@article{Cohen2016TheFI,
  title={The FDA is prohibited from going germline},
  author={Ivan Glenn Cohen and Eli Y. Adashi},
  journal={Science},
  year={2016},
  volume={353},
  pages={545 - 546}
}
Full stop: U.S. Congress precludes human germline modification A potentially renewable provision of the Consolidated Appropriation Act of 2016 forestalling the prospect of human germline modification was signed into law on 18 December 2015 (1). The provision, also known as a rider (an amendment extraneous to the main purpose of the bill to which it is attached), stipulates that “none of the funds made available by this Act [to the FDA] may be used to review or approve an application for an… Expand
Striking a Balance: Policy Considerations for Human Germline Modification
TLDR
The current state of the science and law surrounding HGM, as well as the various ethical principles that underlie current U.S. and international policy, are reviewed and a middle path forward for the development of HGM in the near future is suggested. Expand
What would responsible remedial human germline editing look like?
TLDR
The principles commensurate with an uncompromising translational path toward the clinical conduct of heritable genome editing are explored. Expand
Rewriting the human genome, rewriting human rights law? Human rights, human dignity, and human germline modification in the CRISPR era
TLDR
This article critically examines how realistic the proposed distinction between the therapeutic and the nontherapeutic uses of human germline modification is in the CRISPR era and argues that these proposals rely on a one-dimensional understanding of the meaning of human rights for this issue. Expand
Heritable Human Genome Editing: The Public Engagement Imperative.
TLDR
In this communication, the authors lay out the foundational principles undergirding the formation, modification, and evaluation of public opinion that will determine the societal decision to warrant or enjoin the clinical conduct of HHGE. Expand
Human Germ Line Gene Editing: Why Comparative, Cross-National Studies of Public Viewpoints are Important?
TLDR
The decision to proceed with human germ line editing for research purposes has been reconfirmed by regulatory authorities in various countries, including the UK, where the Human Embryo and Fertilization Authority has approved a license application to use gene editing in research on February 1, 2016. Expand
Estimating Demand for Germline Genome Editing: An In Vitro Fertilization Clinic Perspective.
TLDR
It is suggested that the need for GGE to cure heritable genetic disease is typically grossly overestimated, mainly due to the underappreciated role of preimplantation genetic testing, and that GGE, hereditary genetic disorders, and in vitro fertilization are fundamentally entwined concepts. Expand
Will CRISPR Germline Engineering Close the Door to an Open Future?
TLDR
Feinberg’s 1980 open future theory is extended to the human embryo in the context of CRISPR germline engineering, which alters future generations of the embryo and disregards future autonomy. Expand
Mitochondrial Replacement Techniques: Genetic Relatedness, Gender Implications, and Justice
TLDR
It is argued that morally inadequate and ineffective regulations regarding egg donation, PGD, and germline genetic modifications jeopardize the ethical acceptability of the implementation of MRTs, suggesting that MRT's are currently difficult to justify in the US and Mexico. Expand
Mitochondrial manipulation in fertility clinics: Regulation and responsibility
TLDR
To protect future children, this study underscores the pressing need for regulatory frameworks with policies that cover MMT, and surveyed countries where MMT have been clinically implemented or where such experimental procedures are advertised on the internet. Expand
Beyond Nature? Genomic Modification and the Future of Humanity
Recent breakthroughs have moved heritable human genetic modification from the realm of science fiction to the cusp of reality, lending urgency to questions regarding how and for what purposes newExpand
...
1
2
3
...

References

SHOWING 1-10 OF 18 REFERENCES
A prudent path forward for genomic engineering and germline gene modification
TLDR
The meeting identified immediate steps to take toward ensuring that the application of genome engineering technology is performed safely and ethically, and identified those areas where action is essential to prepare for future developments. Expand
An Obscure Rider Obstructing Science: The Conflation of Parthenotes with Embryos in the Dickey–Wicker Amendment
TLDR
It is argued that the scientific difference between embryos and parthenotes translates into ethical differences, and claim that research on parthenote research is much less ethically problematic. Expand
Mitochondrial Replacement Techniques
Mitochondrial replacement techniques (MRT) are designed to prevent the transmission of mitochondrial DNA (mtDNA) diseases from mother to child, but the techniques raise ethical, social, and policyExpand
House committee on appropriations
A recent United States Supreme Court decision rendered various mandatory minimum sentencing provisions in Pennsylvania law unconstitutional. Senate Bill 1062 amends the Crimes Code and the JudicialExpand
Expert Committee: “FDA should allow mitochondrial replacement trials under certain conditions
  • (Regulatory Affairs Professionals Society,
  • 2016
House Committee on Appropriations, Bill for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for the fiscal year ending
  • 2016
House Committee on Appropriations, Bill for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for the fiscal year ending September 30, 2017, 114th Cong
  • 2d sess.,
  • 2016
Project: Scientific, Medical, and Ethical Considerations of Human Gene Editing (National Academies
  • 2016
Senate Committee on Appropriations, Bill for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for the fiscal year ending
  • 2016
2029-Consolidated Appropriations Act
  • 2015
...
1
2
...